ACSL1 and diabetic kidney disease: Wang et al. demonstrated that ACSL1 contributes to the development of diabetic nephropathy by modulating lipid metabolism and inflammatory responses through PPARα and PPARγ signaling, ACSL1 knockdown was shown to ameliorate disease progression [42].